Alzheimer's Disease β-Amyloid Peptide Is Increased in Mice Deficient in Endothelin-converting Enzyme
Open Access
- 1 January 2003
- journal article
- Published by Elsevier
- Vol. 278 (4), 2081-2084
- https://doi.org/10.1074/jbc.c200642200
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Urokinase‐type plasminogen activator inhibits amyloid‐β neurotoxicity and fibrillogenesis via plasminogenJournal of Neuroscience Research, 2002
- Metabolic Regulation of Brain Aβ by NeprilysinScience, 2001
- A Novel γ-Secretase Assay Based on Detection of the Putative C-terminal Fragment-γ of Amyloid β Protein PrecursorPublished by Elsevier ,2001
- Endothelin-Converting Enzyme Inhibitors: Current Status and PerspectivesJournal of Cardiovascular Pharmacology, 2000
- Metalloendopeptidase EC 3.4.24.15 Is Necessary for Alzheimer's Amyloid-β Peptide DegradationPublished by Elsevier ,1999
- Expression of Endothelin‐Converting Enzyme in Both Neuroblastoma and Glial Cell Lines and Its Localization in Rat HippocampusJournal of Neurochemistry, 1997
- Familial Alzheimer's Disease–Linked Presenilin 1 Variants Elevate Aβ1–42/1–40 Ratio In Vitro and In VivoNeuron, 1996
- Degradation of Amyloid β-Protein by a Serine Protease-α2-Macroglobulin ComplexPublished by Elsevier ,1996
- The endothelin system and its potential as a therapeutic target in cardiovascular diseasePharmacology & Therapeutics, 1996
- ECE-1: A membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1Cell, 1994